Redx Pharma has quickly established itself as one of the largest biotechnology companies in Europe, focused on the development of a wide range of early stage, proprietary small molecule therapeutics to address high unmet medical needs in cancer and infectious disease.
Redx Pharma named Bionow Company of the Year 2013
29 November 2013
Redx Pharma has won the award for Company of the Year at the prestigious annual Bionow Awards.
The Bionow Awards recognise and celebrate excellence within the biomedical and life science sectors across Northern England – showcasing the very best of this world-class sector.
The winners were announced at the prestigious Bionow Annual Awards Dinner on Thursday, November 28, which was attended by over 330 executives from across the biomedical industry.
A major one day conference looking at the critical issues relating to the development of new anti-infectives and the problem of drug resistance.
Alderley Park Conference Centre, 26/11/13
Discovering and developing new therapeutics in the area of infectious disease generating a pipeline of novel antibacterial & antiviral drugs.
Delivering multiple development candidates across a range of mechanistic approaches in cancer treatment.
Finding new intellectual property that supports development of novel agrochemicals with shorter, less costly development cycles.